Multilayer Polypropylene-Polyethylene Packaging for Gamma Sterilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current packaging solutions for pharmaceutical compositions fail to meet the stringent sterilization conditions recommended by the EMA, particularly in terms of resistance to high doses of gamma irradiation, while maintaining the sterility and stability of the pharmaceutical content over long periods.
Innovation Solution
A packaging design featuring a polypropylene inner layer and a low-density polyethylene outer layer, with an optional ethylene vinyl alcohol gas barrier layer, providing enhanced resistance to gamma irradiation and maintaining the sterility and stability of the pharmaceutical content, including the use of anti-UV dyes for added protection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional packaging materials are used, then the packaging is easy to manufacture and has good mechanical properties, but it fails to withstand high doses of gamma irradiation and maintains sterility over long periods
Solution Approach 1:
The patent employs a multilayer composite packaging structure consisting of an inner polypropylene layer (200-800 μm) and an outer polyethylene layer (300-1000 μm), with optional gas barrier layers. This composite structure combines the advantages of different polymers: polypropylene provides mechanical strength and sterility maintenance, while polyethylene provides excellent gamma irradiation resistance and chemical stability. The synergistic combination resolves the contradiction by achieving superior irradiation resistance without sacrificing manufacturability, as each layer can be produced using standard extrusion processes.
Solution Approach 2:
The packaging is divided into multiple functional layers, each designed to perform specific functions: the inner polypropylene layer provides structural integrity and sterility barrier, the outer polyethylene layer provides irradiation resistance and environmental protection, and optional gas barrier layers (ethylene vinyl alcohol or polyglycolic acid) provide oxygen and water vapor barrier. This segmentation allows each layer to be optimized for its specific function while maintaining overall manufacturability through sequential lamination processes.
2Strength
If the packaging is made thicker to increase mechanical strength and radiation resistance, then the resistance to gamma irradiation improves, but the packaging becomes more complex and harder to manufacture
Solution Approach 1:
The patent uses a composite multilayer structure where each layer contributes specific properties: the inner polypropylene layer (200-800 μm) provides mechanical strength and sterility barrier, the outer polyethylene layer (300-1000 μm) provides gamma irradiation resistance and chemical stability, and optional gas barrier layers provide oxygen and water vapor barrier. This composite approach achieves enhanced mechanical strength and radiation resistance without excessive thickness, as each layer is optimized for its specific function. The total thickness remains manageable (500-2000 μm) while achieving the required performance.
Solution Approach 2:
Different regions of the packaging structure have different thicknesses and material compositions optimized for their specific functions. The inner layer contacting the pharmaceutical composition uses polypropylene with thickness optimized for sterility barrier (200-800 μm), while the outer environmental exposure layer uses polyethylene with thickness optimized for irradiation resistance (300-1000 μm). Optional gas barrier layers are positioned at specific locations where oxygen and water vapor barrier are most critical. This local optimization achieves high performance without uniform excessive thickening.
3Reliability
If the packaging uses advanced materials to withstand sterilization conditions, then the sterility maintenance improves, but the manufacturing cost and complexity increase
Solution Approach 1:
The patent employs a multilayer composite structure with the inner polypropylene layer specifically designed for sterility maintenance (200-800 μm thick), the outer polyethylene layer for irradiation resistance (300-1000 μm thick), and optional gas barrier layers for oxygen and water vapor protection. Each layer is manufactured using standard extrusion and lamination processes, avoiding the need for expensive specialized materials. The polypropylene layer provides a robust sterility barrier that withstands gamma irradiation sterilization, while the polyethylene layer provides additional protection and chemical stability. This composite approach achieves superior sterility maintenance without requiring costly advanced materials.
Solution Approach 2:
The packaging is segmented into distinct functional layers, each manufactured and processed separately before assembly. The inner polypropylene layer is manufactured to provide sterility barrier, the outer polyethylene layer is manufactured to provide irradiation resistance, and optional gas barrier layers are manufactured to provide oxygen and water vapor barrier. This segmentation allows each layer to be optimized for its specific function while using standard manufacturing processes, avoiding the need for complex single-material solutions. The layers are laminated together using conventional adhesive or heat-sealing methods.
4Object-affected harmful factors
If the packaging is made more robust to withstand sterilization, then the resistance to harmful factors improves, but the transparency and light protection are compromised
Solution Approach 1:
The patent uses a composite multilayer structure where the inner polypropylene layer (200-800 μm) provides mechanical robustness and sterility barrier, the outer polyethylene layer (300-1000 μm) provides gamma irradiation resistance and chemical stability, and optional gas barrier layers provide oxygen and water vapor barrier. All layers are selected to maintain optical transparency, allowing light transmission for phototherapy applications. The polyethylene layer can be formulated with UV stabilizers and antioxidants to maintain both robustness and transparency. This composite structure achieves resistance to environmental factors including gamma irradiation, oxygen, water vapor, and UV light, while preserving the necessary transparency for the pharmaceutical composition.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The packaging effectively withstands high doses of gamma irradiation, maintains sterility, and ensures the long-term stability of pharmaceutical compositions by preventing oxygen and water permeation, while retaining transparency and mechanical robustness.
Implementation Method 1
packaging comprising at least one polyethylene polymer outer layer with a thickness between 300 and 1000 μm retains its full strength when subjected to high doses of irradiation (around 40 kGy)
Implementation Method 2
preventing oxygen and water permeation
Data Source
AI summary
The present invention concerns packaging for preserving a sterile pharmaceutical composition, comprising at least an inner layer of polypropylene having a thickness of between 200 and 800 µm and an outer layer made from polyethylene, the outer layer being in contact with the environment and having a thickness of between 300 and 1000 µm. The invention also concerns a method for the sterile preservation of a pharmaceutical composition using such packaging.